These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 27686052
21. Co-extrusion as a processing technique to manufacture a dual sustained release fixed-dose combination product. Vynckier AK, Voorspoels J, Remon JP, Vervaet C. J Pharm Pharmacol; 2016 May; 68(5):721-7. PubMed ID: 26751978 [Abstract] [Full Text] [Related]
22. Release characteristics of polyurethane tablets containing dicarboxylic acids as release modifiers - a case study with diprophylline. Claeys B, De Bruyn S, Hansen L, De Beer T, Remon JP, Vervaet C. Int J Pharm; 2014 Dec 30; 477(1-2):244-50. PubMed ID: 25445517 [Abstract] [Full Text] [Related]
23. Can drug release rate from implants be tailored using poly(urethane) mixtures? Lowinger MB, Su Y, Lu X, Williams RO, Zhang F. Int J Pharm; 2019 Feb 25; 557():390-401. PubMed ID: 30529658 [Abstract] [Full Text] [Related]
24. Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs. Zhang S, Meng X, Wang Z, Fan A, Wang G, Zhao Y, Tang Y. Eur J Pharm Sci; 2017 Mar 30; 100():109-115. PubMed ID: 28087352 [Abstract] [Full Text] [Related]
25. Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents. Major I, McConville C. Recent Pat Drug Deliv Formul; 2015 Mar 30; 9(3):194-200. PubMed ID: 27165308 [Abstract] [Full Text] [Related]
26. Development of 3D-printed dual-release fixed-dose combination through double-melt extrusion. Oh HS, Park JB. Int J Pharm; 2024 Aug 15; 661():124407. PubMed ID: 38955239 [Abstract] [Full Text] [Related]
28. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating. Jedinger N, Schrank S, Fischer JM, Breinhälter K, Khinast J, Roblegg E. AAPS PharmSciTech; 2016 Feb 15; 17(1):68-77. PubMed ID: 26206403 [Abstract] [Full Text] [Related]
29. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation. Ochoa L, Igartua M, Hernández RM, Solinís MA, Gascón AR, Pedraz JL. Eur J Pharm Biopharm; 2010 Jun 15; 75(2):232-7. PubMed ID: 20159037 [Abstract] [Full Text] [Related]
30. Injection molding as a one-step process for the direct production of pharmaceutical dosage forms from primary powders. Eggenreich K, Windhab S, Schrank S, Treffer D, Juster H, Steinbichler G, Laske S, Koscher G, Roblegg E, Khinast JG. Int J Pharm; 2016 May 30; 505(1-2):341-51. PubMed ID: 27012981 [Abstract] [Full Text] [Related]
31. Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study. Kallakunta VR, Tiwari R, Sarabu S, Bandari S, Repka MA. Eur J Pharm Sci; 2018 Aug 30; 121():126-138. PubMed ID: 29772273 [Abstract] [Full Text] [Related]
32. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release]. Kołodziejczyk MK, Kołodziejska J, Zgoda MM. Polim Med; 2012 Aug 30; 42(3-4):167-84. PubMed ID: 23457958 [Abstract] [Full Text] [Related]
33. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: In vitro and in vivo evaluation. Verstraete G, De Jaeghere W, Vercruysse J, Grymonpré W, Vanhoorne V, Stauffer F, De Beer T, Bezuijen A, Remon JP, Vervaet C. Int J Pharm; 2017 Jan 30; 517(1-2):88-95. PubMed ID: 27919698 [Abstract] [Full Text] [Related]
34. Comparison of fused-filament fabrication to direct compression and injection molding in the manufacture of oral tablets. Fuenmayor E, Forde M, Healy AV, Devine DM, Lyons JG, McConville C, Major I. Int J Pharm; 2019 Mar 10; 558():328-340. PubMed ID: 30659922 [Abstract] [Full Text] [Related]
35. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion. Maniruzzaman M, Islam MT, Halsey S, Amin D, Douroumis D. AAPS PharmSciTech; 2016 Feb 10; 17(1):191-9. PubMed ID: 26689407 [Abstract] [Full Text] [Related]
36. Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets. Rezaei L, Meruva S, Donovan MD. AAPS PharmSciTech; 2021 Dec 27; 23(1):38. PubMed ID: 34961912 [Abstract] [Full Text] [Related]
37. Evaluation of hot-melt extrusion technique in the preparation of HPC matrices for prolonged release. Loreti G, Maroni A, Del Curto MD, Melocchi A, Gazzaniga A, Zema L. Eur J Pharm Sci; 2014 Feb 14; 52():77-85. PubMed ID: 24211649 [Abstract] [Full Text] [Related]
38. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Sarabu S, Bandari S, Kallakunta VR, Tiwari R, Patil H, Repka MA. Expert Opin Drug Deliv; 2019 Jun 14; 16(6):567-582. PubMed ID: 31046479 [Abstract] [Full Text] [Related]
39. Application of continuous twin screw granulation for the metformin hydrochloride extended release formulation. Kim SH, Hwang KM, Cho CH, Nguyen TT, Seok SH, Hwang KM, Kim JY, Park CW, Rhee YS, Park ES. Int J Pharm; 2017 Aug 30; 529(1-2):410-422. PubMed ID: 28705620 [Abstract] [Full Text] [Related]
40. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. De Brabander C, Vervaet C, Remon JP. J Control Release; 2003 Apr 29; 89(2):235-47. PubMed ID: 12711447 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]